Kansas City's Skoglund suspended
The Office of the Commissioner of Baseball announced today that Kansas City Royals pitcher Eric Skoglund has received an 80-game suspension without pay after testing positive for the Selective Androgen Receptor Modulators S-22 (Ostarine) and LGD-4033 (Ligandrol), both performance-enhancing substances, in violation of Major League Baseball's Joint Drug Prevention and Treatment Program. Skoglund's 80-game suspension will be effective at the beginning of the 2019 regular season.
January 16th, 2019
The Office of the Commissioner of Baseball announced today that Kansas City Royals pitcher Eric Skoglund has received an 80-game suspension without pay after testing positive for the Selective Androgen Receptor Modulators S-22 (Ostarine) and LGD-4033 (Ligandrol), both performance-enhancing substances, in violation of Major League Baseball's Joint Drug Prevention and Treatment Program.
Skoglund's 80-game suspension will be effective at the beginning of the 2019 regular season.